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Abstract
Background: Type 1 Diabetes Mellitus is caused by auto immune destruction of insulin producing beta cells in the pancreas.
Currently available treatments include transplantation of isolated islets from donor pancreas to the patient. However, this
method is limited by inadequate means of immuno-suppression to prevent islet rejection and importantly, limited supply of
islets for transplantation. Autologous adult stem cells are now considered for cell replacement therapy in diabetes as it has
the potential to generate neo-islets which are genetically part of the treated individual. Adopting methods of islet
encapsulation in immuno-isolatory devices would eliminate the need for immuno-suppressants.
Methodology/Principal Findings: In the present study we explore the potential of human adipose tissue derived adult
stem cells (h-ASCs) to differentiate into functional islet like cell aggregates (ICAs). Our stage specific differentiation protocol
permit the conversion of mesodermic h-ASCs to definitive endoderm (Hnf3b, TCF2 and Sox17) and to PDX1, Ngn3, NeuroD,
Pax4 positive pancreatic endoderm which further matures in vitro to secrete insulin. These ICAs are shown to produce
human C-peptide in a glucose dependent manner exhibiting in-vitro functionality. Transplantation of mature ICAs, packed
in immuno-isolatory biocompatible capsules to STZ induced diabetic mice restored near normoglycemia within 3–4 weeks.
The detection of human C-peptide, 11556165 pM in blood serum of experimental mice demonstrate the efficacy of our
differentiation approach.
Conclusions: h-ASC is an ideal population of personal stem cells for cell replacement therapy, given that they are abundant,
easily available and autologous in origin. Our findings present evidence that h-ASCs could be induced to differentiate into
physiologically competent functional islet like cell aggregates, which may provide as a source of alternative islets for cell
replacement therapy in type 1 diabetes.
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Introduction
Type 1 diabetes is characterized by the autoimmune destruction
of b cells, resulting in life-long dependency on insulin injection that
often results in complications of hypo- or hyperglycemia. Although
Edmonton protocol for islet transplantation is the most preferred
therapy available for type 1 diabetes, a major obstacle with this
therapy is the limited supply of cadaveric donor islets in retention
to the high demand of eligible patients and the need for lifetime
immunosuppressant [1–4]. Recent studies have demonstrated that
Embryonic stem cells (ESCs) [5–7], Induced pluripotent stem cells
(IPSs) [8,9], and adult stem cells like bone marrow (BM) [10],
pancreas [11,12], liver [13], umbilical cord blood [14], Wharton’s
jelly [15], placenta [16], could be differentiate into insulin
producing cells. ESCs have tremendous pluripotency, however,
ethical/legal issues and risks of teratoma formation limit its use in
translational medicine. In this scenario, Adipose-derived adult
stem cells (ASCs) appear to be an ideal population of stem cells for
practical cell replacement therapy, given that they are abundant,
autologous tissue and ease in availability [17]. Even lean adult men
and women have at least 3.0–4.5 kg of adipose tissue, and in
individuals with severe obesity, adipose tissue can constitute up to
45 kg or more of body weight [18], sufficient quantities of ASCs
can be harvested and cultured from a minimum of 1.0 g of fat.
Moreover adipose tissue is a remarkable organ that play important
role in glucose homeostasis and hormone production (adipokine)
[19]. Some of the adipokines like leptin and adiponectin have
direct impact on glucose homeostasis and fatty acid oxidation [20].
Findings by Timper et al [21] and Lee et al [22] with human
ASCs and our earlier experience with murine ASCs [23] indicate
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e20615that h-ASCs are the ideal candidates for cell replacement therapy
in diabetes.
In the present study we explore the potential of h-ASCs to
differentiate into functional islet like cellular aggregates (ICAs)
with stage specific differentiation conditions. The differentiated
ICAs are packed in immunoisolation capsules for transplantation
studies. These ICAs when transplanted into STZ induced diabetic
mice can restore near normoglycemia within 3–4 weeks. The
detection of human specific C-peptide in transplanted mice serum
further strength our differentiation approach. Our studies thus
raise the possibility that patient own adipose tissue can serve as a
source of ASCs to differentiate into functional autologous ICAs for
cell replacement therapy in type 1 diabetes.
Results
Human adipose tissue derived adult stem cells (h-ASCs) were
isolated from the resected fat tissue samples (n=6, female donor of
age group 25–50 years) as earlier reported [17,21]. The initial
culture of stromal vascular fraction resulted in the growth of plastic
adherent cell population with typical mesenchymal morphology.
Although freshly isolated h-ASCs showed heterogeneous pheno-
type in culture, single fibroblastoid cell populations were clonally
expanded which exhibited homogenous morphology. Four clones
of h-ASCs were evaluated for all the differentiation studies and all
experiments were carried out using h-ASCs of passages 4–8. The
homogeneity of the cloned population was confirmed by the triple
stained FACS analysis of h-ASCs at passage-4 which showed
uniform co-expression of CD90, CD44 and CD29 surface markers
(Figure 1).
Surface phenotype characterization of h-ASCs with flow
cytometry showed that, unlike murine ASCs, h-ASCs showed
high expression of CD13, CD59, CD105 (Figure S1). h-ASCs
showed expression of cytoskeletal proteins vimentin, alpha-smooth
muscle actin, nestin and extracellular matrix protein fibronectin
(Figure 2, A–D). Cells were highly mitotic in culture and expressed
proliferation marker Ki-67 (Figure 2E). h-ASCs exhibited in-vitro
competence to differentiate into adipogenic, chondrogenic and
osteogenic lineages upon specific induction as confirmed by Oil
red O (Figure 2G), Saffranin-O (Figure 2H) and Alizarin-red
staining respectively (Figure 2I).
Differentiation of h-ASCs to definitive endoderm ICAs
h-ASCs were grown in low adherence culture dishes and
exposed to serum free media (SFM-A) for 2 days. By 24–48 hrs,
cells migrated and clustered to become islet like cells aggregates
(ICAs) (Figure 3). By day 2, the cells started expressing endoderm
markers like HNF-3 beta, TCF-2 and Sox-17 as compared to
undifferentiated h-ASCs (Figure 4A a–c). qRT-PCR analysis of
day2-ICAs showed increased transcript abundance of the
endoderm markers HNF-3 beta/FoxA2 (10
3 fold), CK-19 (10
fold) and Sox-17 (2 fold) as compared to undifferentiated h-ASCs
(Figure 4B) The highest mRNA expression levels of Sox17, a
definitive endoderm marker was observed by day 5.
Pancreatic Endoderm differentiation of ICAs derived from
h-ASCs
In the next stage, to achieve pancreatic endoderm differentia-
tion day2-ICAs were exposed to SFM supplemented with taurine
(SFM-B), a non-essential amino acid involved in the development
of pancreatic b-cells [24,25]. After 2 days of incubation in SFM-B,
in the final stage of differentiation, ICAs were exposed to
differentiation media supplemented with b-cell maturation factors
Figure 1. Uniform co-expression of CD90-CD29-CD44 in clonally expanded h-ASCs. Flow cytometry based characterization of the clonal
population of h-ASCs. Representative profile of clonally expanded h-ASCs (n=4); cells are triple positive for CD90, CD44 and CD29 (.90%) antigens.
Percentage of positivity indicated in top right corner. Three different color conjugated antibodies were used, CD90-APC, CD44-PE and CD29-FITC.
Isotype controls were used for all antibody combinations.
doi:10.1371/journal.pone.0020615.g001
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cytoskeletal protein vimentin (A), alpha smooth muscle actin (B), nestin (C), fibronectin (D) and cell proliferation marker Ki-67 (E) with
immunofluoresence staining. Negative control staining with fluorescence conjugated secondary antibodies shown (F). Cell nuclei were stained with
DAPI. Scale bar, 20 mm. h-ASCs exhibited competence to differentiate into adipogenic, osteogenic and chondrogenic lineages in-vitro upon specific
induction as confirmed by Oil red O (G), Saffranin-O (H) and Alizarin-red (I) staining respectively.
doi:10.1371/journal.pone.0020615.g002
Figure 3. Differentiation strategy for h-ASCs derived ICAs, day 14 ICAs stained positive with islet specific DTZ staining. h-ASCs in
monolayer when exposed to SFM A undergo cell clustering and aggregation. Subsequent exposure and incubation of h-ASCs in SFM B on day 3 and
SFM C on day 5 results in the formation of mature Islet like cell aggregates (ICAs). By day14, the ICAs become fully differentiated and mature and stain
positive for DTZ. Abbreviations: SFM, Serum free media; ITS, Insulin-transferrin-selenium; BSA, Bovine serum albumin, GLP- Glucagon Like Peptide,
DTZ, dithizone.
doi:10.1371/journal.pone.0020615.g003
Generation of Islets from Human Adipose Stem Cells
PLoS ONE | www.plosone.org 3 June 2011 | Volume 6 | Issue 6 | e20615like GLP-1 and nicotinamide (SFM-C) and maintained for
additional 7–8 days. A significant up regulation in the expression
of pancreatic endoderm markers as well as key transcription
factors involved in pancreas development like PDX-1, Ngn3,
NeuroD, Pax-4, Nkx2.2, Nkx6.1, Pax-6, Isl-1 and glucose
transporter Glut-2 were observed in d14- ICAs over undifferen-
tiated h-ASCs (Figure 5).
Transcript levels of PDX-1, Ngn-3, Pax-4 and Isl-1 in d14 ICAs
were comparable to that of 12 week old human fetal pancreas. By
day-14 of differentiation the ICAs stained positive for DTZ, a zinc-
chelating agent known to selectively stain pancreatic beta cells
(Figure 3).
The mature day-14 ICAs showed enhanced transcript levels of
insulin, glucagon, somatostatin, pan-polypeptide and ghrelin as
compared to undifferentiated h-ASCs. The transcript abundance
of pancreatic hormones in mature ICAs was lower than that of
human fetal pancreas (12 week). Undifferentiated h-ASCs
consistently exhibited transcripts of ghrelin (Figure 6A). Scanning
electron microscopy based ultra structural analysis showed typical
islet like surface topography and organization in day 14 ICAs
(Figure 6B).
These results were further confirmed by immuno-staining of
matured day-14 ICAs for islet specific transcription factors and
hormones. Matured day-14 ICAs exhibited abundant expression
of Pdx-1 (Figure 7A), C-peptide (Figure 7B), insulin (Figure 7C),
somatostatin (Figure 7D) and glucose transporter2 (Figure 7E).
Similar to our earlier observation with murine ASCs derived ICAs
(23), the Day 14 human ICAs also showed co-expression of insulin
and somatostatin (Figure S2A). The mature ICAs also showed
proliferative potential depicted by Ki-67 expression (Figure S2B).
The gene profiling studies for adipose tissue-specific markers
during ICA differentiation showed that the transcript level of
Figure 4. Characterization of h-ASCs derived ICAs for endoderm markers. Immuno-staining of ICAs exposed to SFM A on day-2 for the
expression of definitive endoderm markers Foxa2 (HNF3B) (A-a), TCF-2 (A-b) and Sox-17 (A-c) as compared to undifferentiated h-ASCs (top panel of
Figure 4). Nuclei stained with DAPI. Scales bar=20 mm. qRT-PCR data on the expression of definitive endoderm markers Foxa2, CK-19 and Sox-17
during specific stages of differentiation (day 2, day 5 and day 14) ICAs and compared with undifferentiated h-ASCs. All mRNA expression levels were
normalized to the house keeping gene GAPDH expression, data presented here as fold increase of mean6S.E.M over h-ASCs undifferentiated cells (B).
Abbreviations: DAPI, (49, 6-diamidoino-2-phenylindole); CK-19, cytokeratin-19; qRT PCR, quantitative reverse transcription polymerase chain reaction;
GAPDH, glyceraldehyde-3-phosphate-dehydrogenase.
doi:10.1371/journal.pone.0020615.g004
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h-ASCs (Figure S3A). Immunostaining of h-ASCs and d14-ICAs
showed low levels of leptin expression (Figure S3B).
Static stimulation and total C-peptide content of mature
ICAs
In this study, day-14 h-ASCs derived ICAs were first incubated
with 5.5 mM glucose for 1 h to measure the basal level of c-
peptide release which is a direct indicator of the amount of de
novo insulin released. The same ICAs were subsequently
incubated for additional 1 h in 22 mM glucose to measure
glucose-stimulated C-peptide release (n=3). Total C-peptide
content of day 14 ICAs measured up to 47.68615.20 pM per
60 min when exposed to 5.5 mM glucose (p=0.070). When
stimulated with 22 mM glucose, the total C-peptide content of
ICAs increased to 80.6168.92 pM per 60 minute (p=0.05)
confirming their in vitro functionality and ability to respond to
Figure 5. Expression profile of pancreatic endoderm genes during the course of differentiation. h-ASCs when differentiated to mature
ICAs expressed various genes involved in pancreas development. SYBR-Green based qRT PCR was performed for the pancreatic progenitor specific
transcription factors like PDX1, Ngn3, NeuroD, Pax4, Nkx2.2, Nkx6.1, Pax6, Isl1 and glucose transporter Glut-2 at day14 (Diff-d14) of differentiation.
Gene transcripts of ICAs are compared with human fetal pancreas (12 week) (H-Pan). Relative levels of gene expression were normalized to the
GAPDH mRNA level. Transcript abundance is shown here as fold increase of mean6S.E.M. for two experiments and represented as fold over
undifferentiated h-ASCs. Abbreviations: Diff-d14: Differentiated ICAs on day 14 and H-Pan: Human fetal pancreas- 12 week).
doi:10.1371/journal.pone.0020615.g005
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14 differentiated ICAs was calculated and value was compared
with undifferentiated h-ASCs (equal number of starting cells
(2610
6 cells) were taken to compare the two values). It was observe
that h-ASC derived day 14 ICAs contained up to 1.7660.45 mg/l
(582.566148.95 pM) (p=0.02) as compared to 0.05160.006 mg/l
(p=0.005) of C-peptide in undifferentiated h-ASCs (n=3)
(Figure 8B). However in day-14 ICAs cell numbers are potentially
not equal and therefore this makes direct comparison of C-peptide
content difficult.
Mature ICAs show hypoglycemic effect in experimental
diabetic mice
The physiological competence of mature day-14 ICAs to
maintain glucose homeostasis in vivo was evaluated by transplan-
tation of ICAs in STZ induced diabetic mice. ICAs (1000–1200)
encapsulated in calcium-alginate were packed into biocompatible
capsules of PU-PVP-IPN [26] and transplanted into the peritoneal
cavity of diabetic mice (n=6). By 2–3 weeks, mice transplanted
with mature ICAs showed reduction in blood glucose levels. The
mice maintained lowering of blood glucose (180–190 mg/dl) upto
eight week of follow up. However, it was observed that
normoglycemia was not restored in these mice. Transplantation
of undifferentiated h-ASCs (n=6) to STZ-induced diabetic mice
also showed lowering of blood glucose (250 mg/dl) which was
maintained but failed to restore normoglycemia within the
stipulated time (Figure 8C). To determine whether the ICAs
could regulate blood glucose levels independently of the
endogenous pancreatic b-cells, we measured level of human as
well as mouse C-peptide in blood serum of all experimental mice.
We measured up to 11556165 pM (3.4960.50 mg/l) serum level
of human C-peptide in diabetic mice transplanted with day 14
ICAs on day 28 post transplantation. The level of human C-
peptide in mice transplanted with undifferentiated h-ASCs
(2610
6), 28
th days post transplantation measured to
10096383 pM (3.0561.16 mg/l) The mouse C-peptide concen-
tration was found to be very low to undetectable (,0.002 mg/l) in
control diabetic mice (Figure 8D). ICAs retrieved from the
transplanted mice after 4 weeks showed good cellular aggregation
and viability (data not shown). The ICAs and undifferentiated h-
Figure 6. Expression of pancreatic endocrine hormones transcript during the course of differentiation, surface topography of day
14 ICAS with scanning electron microscopy. qRT PCR based transcript abundance of pancreatic hormones (Insulin, Glucagon, Somatostatin,
Pan-pol and Ghrelin) in undifferentiated and day 14 differentiated h-ASCs. Transcript abundance of these genes was also compared to that of human
fetal pancreas 12 week (H-Pan). Relative levels of gene expression were normalized to the GAPDH mRNA level and presented here as fold increase of
mean6S.E.M over detectable (Ct of 39) (A). (White bar: Undifferentiated h-ASCs, Grey bar: Differentiated ICAs on day 14 and Green bar: Human fetal
pancreas- 12 week). Scanning electron microscopy (SEM) of day 14 ICAs show typical surface topography similar to that of pancreatic islets. Scale
bar=200 mm (B) and 100 mm (C). Abbreviations: qRT PCR, quantitative reverse transcription polymerase chain reaction; cDNA, complementary DNA;
pan pol, pancreatic polypeptide; GAPDH, glyceraldehyde-3-phosphate-dehydrogenase.
doi:10.1371/journal.pone.0020615.g006
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peptide expression (Figure S4A and B).
Discussion
In this study we assessed the potential of h-ASCs to produce
functional pancreatic hormone producing islet like cell aggregates
from resected human fat samples. Our isolation protocol for
Stromal vascular fractions consistently yielded multipotent mes-
enchymal cells expressing CD29+/CD44+/CD90+ surface anti-
gen profile. These cells demonstrated high competence to
differentiate to adipogenic, osteogenic and chondrogenic lineages.
h-ASCs isolated in culture differed in its expression of surface
antigens from murine ASCs isolated by similar procedure. h-ASCs
distinctly showed high expression of CD90 and low expression
level of Sca-1 as against m-ASCs [23]. The surface antigen profile
differed from human BM derived mesenchymal cells as well
indicating that despite the similarities in morphology, mesenchy-
mal cells isolated from different sites/tissue of origin possess
distinct molecular signatures and identities. In accordance with
earlier reports, we observed a stringent dependence of h-ASCs on
FGF for proliferation and survival in vitro [27]. Subsequently all
media and differentiation cocktails were supplemented with 2 ng/
ml FGF.
To achieve differentiation to pancreatic lineage, specific step-
wise conditions were formulated as per earlier reported protocol
Figure 7. Confocal immunocytochemistry of day14 ICAs shows the expression of pancreatic endoderm markers. Confocal optical
sections of ICAs stained for PDX-1(a), C-peptide (b), Insulin (c), Somatostatin (d), and Glut 2 (e). Nuclei are stained by DAPI (49, 6-diamidoino-2-
phenylindole). (Scale bar=20 mm).
doi:10.1371/journal.pone.0020615.g007
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mesodermic h-ASCs with activin A, sodium butyrate, 2-mercap-
toethanol, ITS and 2 ng/ml FGF (SFM-A). We found that
addition of FGF stimulate the initial process of cell aggregation
and cluster formation, an important step in the development and
differentiation of pancreas via FGF-receptor on h-ASCs [28].
Definitive endoderm differentiation was identified by the expres-
sion of Hnf3b/Foxa2 in (,80%) [29], TCF-2 [30] and Sox-17
[31] in 50%–60% cells in day 2 differentiated cells. Increased
mRNA expression of Hnf3b, CK-19 and Sox-17 in comparison to
undifferentiated h-ASCs, further confirmed their definitive
endoderm differentiation. Sox-17 and Hnf3b expressions were
highest during day-5 of differentiation. The expression of these
genes occurs in a similar pattern as observed during pancreatic
development. The low cell attachment culture dish and initial high
plating density (2610
6 cells generated around 400–600 ICAs)
proved to be highly efficient in helping cells to form 3D aggregates
similar to our earlier observations with murine ASCs. By 24–36 h
of initial plating, h-ASCs formed clusters (ICAs) with compact
cellular aggregation.
Previous studies have shown that supplementation of taurine, a
non essential amino acid modulate glucose homeostasis and islet
function [24,25]. The taurine supplemented with nicotinamide
and GLP-1 in the differentiation cocktail resulted in the up
regulation of a number of genes (PDX1, Ngn3, NeuroD, Pax4,
Nkx2.2, Nkx6.1, Pax-6, Isl-1 and pancreas specific glucose
transporter Glut-2) involved in pancreatic beta cells development
cascade. Additionally, detectable level of transcripts of two
pancreatic progenitor specific transcription factors Nkx2.2/
Nkx6.1 and Isl-1 in undifferentiated h-ASCs make it more suitable
candidate stem cells to differentiate into pancreatic lineage.
Nkx2.2 and its down stream factor Nkx6.1 participate in the
Figure 8. In-vitro and in-vivo functional characterization of ICAs. Static stimulation assay for day14 ICAs. ICAs were sequentially treated with
low glucose (5.5 mM) and high glucose (22 mM) concentration in triplicate for one hour. Cell supernatants were collected and analyzed for c-peptide
release by EIA assay (p values#0.05) (n=3) (A). Total intracellular c-peptide content of day 14 ICAs (p#0.05) was measure in acid-ethanol and
compared equal number of undifferentiated h-ASCs (p#0.05), (n=3) (B). In-vivo characterization of h-ASCs derived ICAs. Transplantation of day-14
ICAs in STZ induced diabetic Swiss albino mice (n=3+3) showed hypoglycemic effect within two weeks. Day-14 ICAs (1000–1200) were encapsulated
in calcium-alginate and packed into biocompatible capsules (made of PU-PVP-IPN) and transplanted intraperitoneally to diabetic mice. Control group
of animals included sham control of diabetic mice transplanted with empty capsule (n=3) and diabetic mice transplanted with encapsulated
undifferentiated h-ASCs (n=3+3). Overnight fasting blood glucose levels of mice in each experimental group for three week time period is
represented (C). Quantification of human C-peptide in blood serum of mice transplanted with ICAs and diabetic control mice (D). Serum samples of
experimental mice were collected by retro orbital bleeding on 28
th day of transplantation, for the detection of human c-peptide/mouse c-peptide in
blood with ultrasensitive human c-peptide/mouse c-peptide kit were used. Abbreviations: ICAs, Islet like cell aggregates; STZ, streptozotocin; IP-GTT,
intra-peritoneal glucose tolerance test; DAPI, (49, 6-diamidoino-2-phenylindole).
doi:10.1371/journal.pone.0020615.g008
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mice of these factors develop with reduced number of mature b
cells [32].
Mature ICAs showed transcript abundance and expression of
pancreatic endocrine hormones. We observed that cells within the
differentiated ICAs co-express insulin and somatostatin which is in
concordance with earlier reports on newly differentiated mid-
gestational human fetal pancreas cells which co express multiple
hormones [33,34]. Glucose static stimulation index of mature d 14
ICAs measured upto 1.69 for C-peptide. Total intracellular
human C-peptide content in day 14 ICAs was 1.7660.45 mg/l.
As our differentiation cocktail includes ITS, to rule out any
possibilities that insulin might be absorbed by cells during in vitro
culture [35,36], we always calculated the level of human c-peptide
for de novo synthesis of insulin. Previous reports on the
differentiation potential of human ASCs by Timper et al and
Lee et al [21,22] although novel, did not demonstrate in vitro/
invivo functionality of the differentiated cells. To the best of our
knowledge this is the first study demonstrating in vitro/in vivo
functionality of ICAs differentiated from h-ASCs.
STZ induced mice were considered diabetic when the blood
glucose levels were higher than 200 mg/dl. For in vivo
transplantation studies we used PU-PVP-IPN biocompatible
capsules as an immuno-isolatory devise. Our initial studies have
shown that a minimum of 1000–1200 ICAs/capsule/mice is
required to achieve significant hypoglycemia in STZ induced
diabetic mice. The capsule exhibited biocompatibility and did not
evoke any immune rejection in the implanted mice. The porosity
of the capsule is such that it easily allows nutrient exchange
between the packed ICAs and the peritoneal cavity. By three
weeks, all the mice transplanted with ICAs, showed lowering of
blood glucose levels and maintained the status for two months of
tracking. However, transplanted ICAs could not bring down blood
glucose to normal physiological levels. This may be circumvented
by optimizing the number of ICAs to be transplanted to
experimental mice. To determine whether the h-ASCs derived
ICAs could regulate blood glucose levels independently of the mice
endogenous pancreatic b cells; we have estimated human C-
peptide level in serum of experimental mice. Random serum levels
of human C-peptide after four weeks of transplantation was
measured up to 11556165 pM (3.4960.50 mg/l) (n=3), is
comparable with the earlier reports with human embryonic stem
cells [37] where they found serum levels of human C-peptide up to
8526263 pM fasting and 23616565 pM in glucose stimulated. It
was interesting to observe that transplantation of undifferentiated
h-ASCs to STZ induced diabetic mice showed moderate lowering
of blood glucose levels, which also reflected in the serum levels of
human C-peptide10096383 pM (3.0561.16 mg/l). This shows
that the autocrine and paracrine factors of regenerating pancreas
and hyperglycemic local diabetic micro-environment of mice may
contribute to a small extend, the differentiation of ASCs as earlier
reported for human bone marrow MSCs [38]. This observation
calls for detail studies to explore the potential of h-ASCs to
differentiate into pancreatic lineage and regulate glucose homeo-
stasis with minimum manipulation. We also checked the pattern of
some of adipokines (leptin and adiponectin) during the course of
differentiation. It was found that the after initial down regulation
of these genes they reappear at the end of differentiation. Leptin
and adiponectin are considered to be good adipokines that play
important role in glucose homeostasis and fatty acid oxidation.
The role of adipokines in glucose metabolism is a highly studied
subject. Earlier reports show that in-vitro chronic exposure of
human islets to leptin induced IL-1beta, leading to impair beta cell
function [39]. However recent studies demonstrate that Leptin
monotherapy improves several of the metabolic imbalances caused
by insulin deficient type 1 diabetes in rodents by CNS dependent
mechanism [40]. It would be interesting to find out whether these
adipokines play any regulatory role in glucose homeostasis in h-
ASC derived ICAs. Scanning electron microscopy based ultra-
structural comparison of these 3D ICAs revealed that their surface
topography and arrangement between cells is very similar to that
of normal pancreatic islets [41]. All the four clones used in this
study exhibited equal frequency of in vitro differentiation and
maturation to ICAs. The inherited expression of Isl-1/Pax-6/
Nkx6.1/Somatostatin transcripts in h-ASCs, its ease in availability
and autologous origin, make it an eminent candidate for cell
replacement therapy in diabetes. To the best of our knowledge this
is the first detailed report demonstrating the differentiation
potential of human ASCs to glucose responsive pancreatic
hormone expressing islet like cellular 3D aggregates. We anticipate
that our work would add on to the ongoing research to find
alternative sources of islets for cell replacement therapy in type 1
diabetes.
Conclusion
Our findings present evidence that h-ASCs could be induced to
differentiate into physiologically functional islet like cell aggre-
gates, which may provide a source of alternative islets for cell
replacement therapy in type 1 diabetes.
Materials and Methods
ASCs Cell Isolation and Expansion
Resected fat tissue samples were obtained during different
abdominal surgeries from female donors (20 to 40 years old).
Collection of the sample was approved by the institutional review
board (IEC-Institutional ethical committee, NCCS, National
Center for Cell Science, Pune) and written consent was obtained
from all donors. Adipose tissue samples (n=6) were washed and
digested in PBS supplemented with 2% bovine serum albumin
(BSA) and 0.2% collagenase-type-II (Sigma-Aldrich, St. Louis,
http://www.sigmaaldrich.com) pre-warmed to 37uC for 45 min-
utes. The cells were centrifuged (400 g for 4 minutes) at room
temperature (RT) in 1–2 ml sterile PBS containing 2% (v/v) fetal
bovine serum (FBS) (Sigma-Aldrich). Supernatant containing
mature adipocytes were discarded. The pellet containing stromal
vascular fraction was resuspended in expansion medium.
Expansion medium. Dulbecco’s modified eagle’s medium
[DMEM]/Ham’s F-12 (GIBCO) with 10% FBS, antibiotics and
supplemented with 2 ng/ml Fibroblast Growth Factor (FGF,
Sigma-Aldrich #F0291). . The cells were plated at density of
2610
5/cm
2 into T25 culture flasks.
Serial dilution method was used to generate single-cell
clonogenic culture. Briefly, 10
4 isolated human ASCs (h-ASCs)
were suspended in 1 ml culture medium. Repeated serial dilution
was carried out to achieve a final dilution of 100 cells in 10 ml
medium. For single-cell culture, 100 ml of the diluted cell
suspension was transferred into each well of a 96-well plate
containing 100 ml of culture medium.
In Vitro Differentiation of mE-ASCs to ICAs
Differentiation was carried out in three stages as reported earlier
[23]. Cells were counted for initial seeding density and 1610
6
cells/cm
2 were resuspended in SFM-A and plated to ultra-low
attachment tissue culture plates (Corning, Fisher scientific) or small
glass petri plate (8610
6 Cells in 20 glass petri plate makes ,800–
1200 ICAs). SFM-A contained DMEM/F12 (1:1) (GIBCO) with
17.5 mM glucose, 1% BSA Cohn fraction V, fatty acid free
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5 mg/L insulin+5 mg/L transferrin+5 mg/L selenium), 4 nM
activin A, 1 mM sodium butyrate, 50 mM 2-mercaptoethanol
and 2 ng/ml Fibroblast Growth Factor. The cells were cultured in
this media for 2 days. On 3
rd day media was changed to SFM-B
that contained DMEM/F12 (1:1) with 17.5 mM glucose, 1% BSA,
ITS and 0.3 mM Taurine. The cell aggregates were cultured in
this medium for another 2 days and shifted to SFM-C on 5
th day.
SFM-C contained DMEM/F12 (1:1) with 17.5 mM glucose, 1.5%
BSA, ITS, 3 mM Taurine, 100 nM Glucagon-like peptide 1
(GLP-1) (amide fragment 7–36, Sigma Aldrich), 1 mM nicotin-
amide and 16 non-essential amino acids (NEAA). The cell
aggregates were fed with fresh SFM-C medium every 2 days for
another 12–14 days. All chemicals were purchased from Sigma
Aldrich unless otherwise indicated.
Quantitative Real-Time Polymerase Chain Reaction
Tissue/Cells samples were frozen in Trizol (Invitrogen,
Carlsbad, CA). Total RNA was isolated from duplicate and
triplicate samples as per the manufacturers’ instructions, measured
on ND-100 spectrophotometer (Nanodrop Techno lies, Wilming-
ton, DE) and 2 mg of RNA was used for cDNA synthesis per 20 ml
reaction. cDNA was amplified using Reverse Transcription
System Kit (ImPromII Reverse-transcription-system(#A3800),
Promega-Corporation, Madison, USA). The primer-sequences
used for quantitative real-time polymerase chain reaction (qRT-
PCR) are summarized in supplementary Table S1. qRT-PCR was
performed in duplicate and triplicate of total 25 ml reaction
mixture containing 16Power SYBR-Green Master-mix (Applied-
Biosystems, http://www.appliedbiosystems.com), 600–750 nM
each forward and reverse primers using 1/20
th of the cDNA
preparation. PCR amplification was carried out using Applied-
Biosystem7300 Real-Time PCR Sequence detection System (SDS-
v1 3.1; Applied-Biosystems) (program: 2 minutes at 50uC,
10 minutes at 95uC, and 40 cycles of 15 seconds at 95uC and
1 minute at 60uC). All qRT-PCR results were normalized to
GAPDH carried out in parallel in duplicate to correct differences
in RNA input. For estimation of fold changes by qRT-PCR when
the initial transcript levels were undetectable, the initial Ct value
was assigned to be 39, which would lead to a possible
underestimation of the actual fold change. The qRT-PCR values
are mean6 S.E.M.
Immunophenotyping (Flow-Cytometric analysis)
Flow-cytometry was performed on a BD-FACS-Canto
TM Flow-
cytometer (www.bdbiosciences.com) and analysis was done with
BD-FACS Diva softwarev5.0. Cells were harvested in 0.25%
trypsin/EDTA, washed in Flow-cytometry buffer (FCB) (16PBS,
0.5%FBS, 0.5%BSA, 0.05%sodium-azide). Cells were stained with
the PE or FITC conjugated antibodies. ICAs were dissociated with
0.25% trypsin-EDTA (Sigma-Aldrich) at 37uC for 10–12 minutes.
The sources of antibodies and dilutions used are summarized in
supplementary Table S1.
Immuno-cytochemistry (Confocal-microscopy)
Cultured cells or ICAs were fixed with freshly prepared 4%
Para-formaldehyde (PFA) for 10 minutes at RT and permeabilized
with either 0.1% Triton X-100 for 3–5 minutes on ice or with
50% chilled methanol for 20 minute on ice. Blocking done with
blocking buffer (PBS, 0.5% FBS and 0.5% BSA) for 30 min at RT.
Primary antibodies were incubated overnight at 4uC, washed with
PBS and then incubated with the secondary antibodies at RT for
1 h. Slides were washed in PBS and mounted with Vectashield
(Vector-Laboratories, CA, http://www.vectorslab.com). DAPI (49,
6-diamidoino-2-phenylindole) (Invitrogen) was used to visualize
nuclei. The sources of antibodies and dilutions used are
summarized in supplementary table S1. Confocal images were
captured using a Zeiss-LSM 510 laser scanning microscope using a
636/1.3 oil objective with optical slices. ,1–2 mm. All results are
representative fields confirmed from at least 5 different exper-
iments.
In Vitro multilineage Differentiation Studies
Adipogenesis, chondrogenesis and osteogenesis for h-ASCs were
carried out in the appropriate induction media according to the
manufacturer’s protocol (Cambrex, MD http://www.cambrex.
com). The differentiation phenotype was documented using oil
red-O for adipocytes, Saffranin-O staining for chondrocytes and
Alizarin staining for osteocytes. Dithizone (DTZ) (Sigma-Aldrich)
stain of 10 mg/ml in DMSO (dimethyl sulphoxide) concentration
used to stain islet like cell aggregates (ICAs).
Total insulin content and release assays
For glucose stimulated insulin release assay, about 200–300 day-
14 ICAs were handpicked in eppendorf tube. ICAs were then
washed three times with PBS and incubated with freshly prepared
KRBH buffer (120 mM NaCl, 5 mM Kcl, 2.5 mM CaCl2,
1.1 mM MgCl2, 25 mM NaHCO3, with 10 mM HEPES buffer
and 0.1% BSA) without glucose for 3 to 6 h. ICAs were incubated
with 100 ml KRBH buffer containing 5.5 mM glucose for 1 h at
37uC. The supernatant were collected and the same ICAs were
further incubated 22 mM glucose for additional 1 h at 37uC. The
human C-peptide concentrations were measured using (Ultra
sensitive human C-peptide EIA kit, Mercodia, Uppsala, Sweden),
mouse C-peptide concentrations were measured using mouse C-
peptide I+II EIA kit (#YK013, Yanaihra Institute Inc., Japan,
www.yanaihara.com). Total Intracellular C-peptide was extracted
by incubating ICAs/h-ASCs overnight in acid ethanol (18 ml
10 M HCl/liter 70% ethanol) at 4uC. The total C-peptide content
of ICAs was estimated after sonicating the ICA pellet in 200 ml
acid/ethanol. The conversion factor for human C-peptide is 1 mg/
l corresponds to 331 pmol/l (pM).
In-vivo transplantation studies
Male Swiss albino mice aged 8–10 weeks were used for
transplantation studies. The study was conducted adhering to the
institution’s guidelines for animal husbandry and has been
approved by IAEC-NCCS/CPCSEA (Institutional animal ethical
committee-NCCS/Committee for the Purpose of Control and
Supervision of Experiments on Animals. Approval number:
IACUC-Institutional Animal Care and Use Committee, EAF-
Experimental Animal Facility/2006/B-56). Streptozotocin (STZ,
Sigma-Aldrich) was injected intraperitoneally at 160 mg/kg of
body weight, freshly dissolved in citrate buffer (pH 4.5). Blood
glucose (BG) was measured by ACCU-CHEK (Roche, www.
roche.com) from snipped tail. Only mice with BG levels stably
above 200 mg/dl after the STZ injection were used for
transplantation studies. For transplantation, around 1000–1200
day-10 ICAs were washed with PBS, suspended in 100 mlo f
sodium-alginate solution (1?2% w/v Alginic acid; Sigma-Chem-
ical, USA, in 0?85% saline), packed into a biocompatible capsule
(Polyurethane-Poly vinyl pyrrolidone-Interpenetrating network
(PU-PVP-IPN), developed by SCTIMST, Kerala, India [23].
The ICAs-alginate capsule were sealed and dipped into 0?1N
acetic-acid and CaCl2 (0?15 M in distilled water) solution for
gelling. These encapsulated ICAs were then implanted into the
peritoneal cavity of diabetic mice. Fasting blood glucose levels
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fasted for 6 h.
Scanning Electron microscopy (SEM)
The differentiated ICAs were incubated in 2.5% phosphate
buffer (0.1 M, pH 7.4) glutaraldehyde solution for 24 hrs. The
tissue was post fixed in 1% OsO4 for 2 h at 4uC, dehydrated and
dried. Specimens were then glued onto stubs, covered with gold in
an S150 sputter coater and examined with a Hitachi S4000 field-
emission (Hitachi Ltd. Tokyo, Japan) scanning electron micro-
scope operating at 10 kV. (IIT, Mumbai).
Statistical Analysis
Values are expressed as mean fold change 6 S.E.M. from three
different experiments unless otherwise indicated. Statistical
analysis was done using Student’s two tailed, t-test to determine
the significance between different conditions. Prism4, Graphpad
Software, San Diego, (http://www.graphpad.com) was used for all
analysis.
Supporting Information
Figure S1 FACS based surface phenotypic characteriza-
tion of h-ASCs. h-ASCs clones at passage4 (n=4), cells were
harvested and labeled with antibodies against CD44-PE, CD13-
PE, CD73-PE, CD90-PE, CD105-PE, CD59-PE, CD166-PE,
CD38-PE, CD14-PE, CD71-PE, CD117-PE and Isotype control
immunoglobulin-G PE and analyzed by FACS. Abbreviations:
FACS, fluorescence-activated cell sorting; PE, phycoerythrin.
(TIF)
Figure S2 Characterization of day 14 ICAs. Immunostain-
ing of day 14 ICAs for the expression of insulin and somatostatin
(A), proliferation marker Ki-67 and insulin (B). The nuclei of the
cells were stained with DAPI (49, 6-diamidoino-2-phenylindole)
(Scale bar=20 mm).
(TIF)
Figure S3 Expression of adipose tissue specific markers
during the course of differentiation. SYBR-Green based
qRT-PCR analysis was carried out for day5 (Dif-d5) and day10
(Dif-d10) ICAs for adipose tissue specific markers like leptin, and
adiponectin compared with undifferentiated h-ASCs (Undiff).
Relative levels of gene expression were normalized to the GAPDH
mRNA level(A). h-ASCs and day 14 ICAs are stained for the
adipokine leptin (B). The nuclei of the cells were stained with
DAPI (49, 6-diamidoino-2-phenylindole) (Scale bar=20 mm).
(TIF)
Figure S4 Immunocytochemical characterization of 4-
week in-vivo transplanted ICAs and h-ASCs. Immunoflu-
orescence staining of the retrieved ICAs after 28 days post-
transplantation for the expression of C-peptide (Red) and insulin
(green) (A). Encapsulated 4 week old transplanted h-ASCs also
show c-peptide (red) and insulin (cyan) (B). The nuclei of the cells
were stained blue with DAPI (49, 6-diamidoino-2-phenylindole)
(Scale bar=20 mm).
(TIF)
Table S1 List of primers and antibodies used in this study.
(DOC)
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